Discover 1,729 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,729
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT01137643
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
for
Prostate Cancer
Location: Durham NC, Roanoke VA, Athens GA, Washington D.C. DC,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT05803941
Recruiting
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
for
Propionic Acidemia
Location: Durham NC, Philadelphia PA, New York NY, Ann Arbor MI,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 0+
Code: NCT04159103
Phase1, Phase2, Recruiting
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
for
Prostate Cancer
Location: Durham NC, Basking Ridge NJ, Middletown NJ, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Male
Age: 18+
Code: NCT06457919
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Proton or Photon RT for Retroperitoneal Sarcomas
for
Retroperitoneal Sarcoma
Location: Durham NC, Buffalo NY, Chicago IL, St Louis MO,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT01659203
Phase1, Phase2, Recruiting
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
for
Metastatic Uveal Melanoma
Location: Durham NC, Knoxville TN, Washington D.C. DC, Atlanta GA,
Sponsor: Replimune Inc.
Sex: All
Age: 0+
Code: NCT06581406
Phase2, Phase3, Recruiting
Project Mountain - Comparing SpO2 and SaO2 for Accuracy
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Durham NC, Pinehurst NC, Lynchburg VA, Gaffney SC,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase2, Phase3, Recruiting
Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL
for
PTCL
Location: Durham NC, Charlottesville VA, New York NY,
Sponsor: University of Virginia
Sex: All
Age: 18+
Code: NCT04747236
Phase2, Recruiting
International CRDS Registry
for
Calcium Release Deficiency Syndrome
Location: Durham NC, Fairfax VA, London, Hamilton, Ottawa,
Sponsor: Population Health Research Institute
Sex: All
Age: 0+
Code: NCT06508164
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Durham NC, Gaffney SC, Florence SC, Union SC,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase3, Recruiting
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
for
Alzheimer Disease
Location: Durham NC, Decatur GA, Toms River NJ, The Villages FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 50 - 70+
Code: NCT06297590
Phase1, Recruiting
The APS Phenotyping Study
for
ARDS, Sepsis, Pneumonia
Location: Durham NC, Baltimore MD, Cincinnati OH, Philadelphia PA,
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 18+
Code: NCT06521502
Recruiting
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
for
Lung Transplant; Complications,
Location: Durham NC, Falls Church VA, Baltimore MD, Pittsburgh PA,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06399302
Recruiting
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation